Acusurgeon’s mission is to develop intuitive, precise, rapid platform technologies, devices, methods, systems for minimally invasive surgeons focusing on minimizing surgical time, and maximizing patient accessibility and outcomes.

Bairitone is building a scalable diagnostic system for sleep apnea anatomy utilizing a home-use wearable, passive Sonar technology, & AI techniques

Cardiost is engineering next-generation mechanical circulatory support devices specifically designed to treat patients with late-stage Heart Failure with Preserved Ejection Fraction (HFpEF), addressing the unmet need for durable, physiologically targeted intervention.

Contrario Medical a preclinical stage medical device company focused in the rapidly growing Assisted Reproductive Technology space.

Corveus Medical is developing a catheter-based solution that treats congestive heart failure by performing a single denervation procedure.

Fluens Medical is developing a minimally-invasive implantable device to address ascites, a life-threatening complication of advanced liver disease.

Merge helps early-stage medical device technology get traction and advance toward clinical use by streamlining development activities to overcome first stages of commercialization.

Motif Neurotech is a cutting-edge neurotechnology company focused on developing implantable brain stimulators to treat neurological disorders. Their innovative solutions aim to transform the landscape of brain health by providing targeted, effective therapies that improve patients’ quality of life.

M&S Biotics developed an autonomous IoT solution to detect, track, count, and locate surgical items within the operating room in real-time. This effectively automates the surgical counting process while providing downstream analytics regarding instrument utilization.

MS Pen is a tech bio company commercializing AI-powered molecular devices to guide surgical decision-making and treatment options for patients with cancer.

In stroke, time is brain. NeuraStasis is driven by its mission to improve stroke care by developing novel neurostimulation technologies that provide protection and enhance recovery in stroke survivors.

Noleus Technologies is dedicated to advancing post-surgery outcomes by reducing swelling. Our pioneering product targets postoperative ileus, setting a new standard with proprietary technology that expedites bowel function recovery after abdominal surgery.

OptiLung is redesigning ECMO with a 3D-printed, clot-resistant device to make life-saving lung support safer and more accessible.

OrganVive is a pioneering medical technology company dedicated to transforming organ transplantation through advanced ex vivo organ preservation platforms.

Prana Thoracic (Houston, TX) – Prana Thoracic is dedicated to developing solutions for the detection and intervention of early-stage lung cancer. They are developing the first minimally invasive, tissue-sparing nodulectomy tool for early interception of suspicious pulmonary nodules.

Previze.AI develops PathFRAX, an AI tool that predicts spinal fractures in cancer patients early, enabling preventive care and better outcomes.

Surf Therapeutics is developing a unique non-invasive neuromodulation platform to treat chronic inflammatory disorders by stimulating the spleen-brain axis, known as the cholinergic anti-inflammatory pathway, which helps control inflammation.

Taurus Vascular is pioneering a new era of aortic aneurysm treatment. At Taurus Vascular, we are developing a catheter-based technology aimed at improving endovascular aneurysm repair (EVAR) by providing a comprehensive solution for endoleak treatment and prevention, ultimately reducing complications and improving long-term patient outcomes.

TYBR Orthopedic surgeons prioritize speed and efficiency. Our hydrogel offers quick, reliable, cost-effective solutions for post-op recovery, safeguarding soft tissue structures, reducing pain, enhancing functionality, and expediting full recovery.

We are Vivifi Medical, a MedTech startup located in Houston TX. Our revolutionary minimally invasive treatment addresses Benign Prostatic Hyperplasia (BPH) through a laparoscopic approach by connecting two blood vessels. Our mission is to surpass the current standard of care and restore freedom, independence, and quality of life to all patients living with BPH.